Transversal–Longitudinal Pathogenetic Theory (TLPT)

Akbar, A. N., & Henson, S. M. (2011). Are senescence and exhaustion intertwined or distinct processes? Nature Reviews Immunology, 11, 289–295.

Barabási, A. L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12(1), 56–68. https://doi.org/10.1038/nrg2918

Berger, J., & Moller, D. E. (2002). The mechanisms of action of PPARs. Annual Review of Medicine, 53, 409–435.

Berdasco, M., & Esteller, M. (2019). Clinical epigenetics: Seizing opportunities for translation. Nature Reviews Genetics, 20(2), 109–127.

Blackburn, E. H., Epel, E. S., & Lin, J. (2015). Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. American Journal of Epidemiology, 182(5), 375–384.

Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000). Role of transforming growth factor β in human disease. New England Journal of Medicine, 342(18), 1350–1358.

Chang, H. C., & Guarente, L. (2014). SIRT1 and other sirtuins in metabolism. Trends in Endocrinology & Metabolism, 25, 138–145.

Chen, J., Liu, B., Yao, X., Yang, X., Sun, J., Yi, J., Xue, F., Zhang, J., Shen, Y., Chen, B., & Sun, H. (2025). AMPK/SIRT1/PGC-1α signaling pathway: Molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy. CNS Neuroscience & Therapeutics, 31(11), e70657. https://doi.org/10.1111/cns.70657

Coppé, J. P., Patil, C. K., & Campisi, J. (2010). The senescence-associated secretory phenotype. Annual Review of Pathology, 5, 99–118.

Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007). Endothelial function and dysfunction: Testing and clinical relevance. Circulation, 115(10), 1285–1295.

Drucker, D. J. (2018). Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism, 27, 740–756.

Evans, R. M., Barish, G. D., & Wang, Y. X. (2004). PPARs and the complex journey to obesity. Nature Medicine, 10, 355–361.

Ferrell, J. E., & Xiong, W. (2001). Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. Chaos, 11(1), 227–241. https://doi.org/10.1063/1.1349894

Förstermann, U., & Sessa, W. C. (2012). Nitric oxide synthases: Regulation and function. European Heart Journal, 33, 829–837.

Garcia, D., & Shaw, R. J. (2017). AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance. Molecular Cell, 66, 789–800.

Guo, H., Callaway, J. B., & Ting, J. P. (2015). Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nature Medicine, 21, 677–687.

Haigis, M. C., & Sinclair, D. A. (2010). Mammalian sirtuins: Biological insights and disease relevance. Annual Review of Pathology, 5, 253–295.

Hardie, D. G. (2015). AMPK: Positive and negative regulation, and its role in whole-body energy homeostasis. Current Opinion in Cell Biology, 33, 1–7.

Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012). AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology, 13, 251–262.

Hayden, M. S., & Ghosh, S. (2008). Shared principles in NF-κB signaling. Cell, 132, 344–362.

Holst, J. J. (2007). The physiology of glucagon-like peptide-1. Physiological Reviews, 87, 1409–1439.

Huang, Q., Ren, Y., Yuan, P., Huang, M., Liu, G., Shi, Y., Jia, G., & Chen, M. (2024). Targeting the AMPK/Nrf2 pathway: A novel therapeutic approach for acute lung injury. Journal of Inflammation Research, 17, 4683–4700. https://doi.org/10.2147/JIR.S467882

Kauffman, S. A. (1993). The origins of order: Self-organization and selection in evolution. Oxford University Press.

Keith, B., Johnson, R. S., & Simon, M. C. (2012). HIF1α and HIF2α: Sibling rivalry in hypoxic tumour growth and progression. Nature Reviews Cancer, 12, 9–22.

Kim, M. H., & Kim, H. (2017). The roles of short-chain fatty acids in intestinal homeostasis and immunity. Immune Network, 17, 69–77.

Kitano, H. (2002). Systems biology: A brief overview. Science, 295(5560), 1662–1664. https://doi.org/10.1126/science.1069492

Laplante, M., & Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell, 149(2), 274–293.

Lawrence, T. (2009). The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1, a001651.

Li, X. (2013). SIRT1 and energy metabolism. Acta Biochimica et Biophysica Sinica, 45, 51–60.

Loscalzo, J., Kohane, I., & Barabási, A. L. (2007). Human disease classification in the postgenomic era: A complex systems approach. Molecular Systems Biology, 3, 124. https://doi.org/10.1038/msb4100163

Ma, Q. (2013). Role of Nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology, 53, 401–426.

Massagué, J. (2012). TGF-β signaling in development and disease. Cell, 147, 275–284.

Milligan, G., Shimpukade, B., Ulven, T., & Hudson, B. D. (2017). GPR41 and GPR43 as therapeutic targets for metabolic diseases. Current Opinion in Pharmacology, 37, 1–7.

Moncada, S., & Higgs, A. (1993). The L-arginine–nitric oxide pathway. New England Journal of Medicine, 329, 2002–2012.

Morikawa, M., Derynck, R., & Miyazono, K. (2016). TGF-β and the TGF-β family: Context-dependent roles in cell and tissue physiology. Cold Spring Harbor Perspectives in Biology, 8, a021873.

Nauck, M. A., & Meier, J. J. (2018). Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism, 20, 5–21.

Quintana, F. J., & Sherr, D. H. (2013). Aryl hydrocarbon receptor control of adaptive immunity. Pharmacological Reviews, 65, 1148–1161.

Rothhammer, V., & Quintana, F. J. (2019). The aryl hydrocarbon receptor: An environmental sensor integrating immune responses in health and disease. Nature Reviews Immunology, 19, 184–197.

Sandoo, A., van Zanten, J. J., Metsios, G. S., Carroll, D., & Kitas, G. D. (2010). The endothelium and its role in regulating vascular tone. Open Cardiovascular Medicine Journal, 4, 302–312.

Saxton, R. A., & Sabatini, D. M. (2017). mTOR signaling in growth, metabolism, and disease. Cell, 168(6), 960–976.

Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews Cancer, 3, 721–732.

Semenza, G. L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell, 148, 399–408.

Stockinger, B., Di Meglio, P., Gialitakis, M., & Duarte, J. H. (2014). The aryl hydrocarbon receptor: Multitasking in the immune system. Annual Review of Immunology, 32, 403–432.

Swanson, K. V., Deng, M., & Ting, J. P. (2019). The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nature Reviews Immunology, 19, 477–489.

Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014). The role of short-chain fatty acids in health and disease. Advances in Immunology, 121, 91–119.

Tilg, H., & Zmora, N. (2020). Gut microbiota and metabolic inflammation. Nature Reviews Immunology, 20, 40–54.

Tschopp, J., & Schroder, K. (2010). NLRP3 inflammasome activation: The convergence of multiple signaling pathways. Nature Reviews Immunology, 10, 210–215.

Wallace, D. C. (2010). Mitochondrial DNA mutations in disease and aging. Environmental and Molecular Mutagenesis, 51(5), 440–450.

Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018). The KEAP1–NRF2 system: A thiol-based sensor–effector apparatus for maintaining redox homeostasis. Physiological Reviews, 98, 1169–1203.

Zhang, Q., Lenardo, M. J., & Baltimore, D. (2017). 30 years of NF-κB: A blossoming of relevance to human pathobiology. Cell, 168, 37–57.

Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011). mTOR: From growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology, 12, 21–35.